Advertisement

The Role of Active Demethylation in Cancer and Its Therapeutic Potential

  • Moshe Szyf
  • Paul M. Campbell
  • Nancy Detich
  • Jing Ni Ou
  • Stefan Hamm
  • Veronica Bovenzi
Chapter
  • 910 Downloads
Part of the Medical Intelligence Unit book series (MIUN)

Abstract

Regional hypermethylation and global hypomethylation coexist in cancer cells. Under-standing the mechanisms responsible for global hypomethylation and regional hypermethylation in cancer is required for the proper design of therapeutic strategies targeting the DNA methylation machinery. This chapter discusses different models explaining this paradox. Global hypomethylation is proposed to be associated with activation by demethylation of metastasis-associated genes. Thus, anticancer therapy directed at DNA methyltransferase might have the untoward effect of promoting metastasis. Inhibition of demethylase activity on the other hand could potentially inhibit metastasis. It is therefore important to identify and characterize the enzymes responsible for global hypomethylation in cancer.

Keywords

Histone Acetylation Histone Methylation Global Hypomethylation Active Demethylation Demethylase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Szyf M, Knox DJ, Milutinovic S et al. How does DNA methyltransferase cause oncogenic transformation? Ann N Y Acad Sci 2000; 910:156–74 discussion 75–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Szyf M. Towards a pharmacology of DNA methylation. Trends Pharmacol Sci 2001; 22:350–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Milutinovic S, Knox JD, Szyf M. DNA methyltransferase inhibition induces the transcription of the tumor suppressor p21(WAF1/CIP1/sdi1). J Biol Chem 2000; 275:6353–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Knox JD, Araujo FD, Bigey P et al. Inhibition of DNA methyltransferase inhibits DNA replication. J Biol Chem 2000; 275:17986–90.PubMedCrossRefGoogle Scholar
  5. 5.
    MacLeod AR, Szyf M. Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J Biol Chem 1995; 270:8037–43.PubMedCrossRefGoogle Scholar
  6. 6.
    Fournel M, Sapieha P, Beaulieu N et al. Down-regulation of human DNA-(cytosine-5) methyltransferase induces cell cycle regulators p16(ink4A) and p21(WAF/Cip1) by distinct mechanisms. J Biol Chem 1999; 274:24250–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Ramchandani S, MacLeod AR, Pinard M et al. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc Natl Acad Sci USA 1997; 94:684–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Feinberg AP, Vogelstein B. Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun 1983; 111:47–54.PubMedCrossRefGoogle Scholar
  9. 9.
    Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301:89–92.PubMedCrossRefGoogle Scholar
  10. 10.
    Ehrlich M. DNA methylation in cancer: Too much, but also too little. Oncogene Aug 12; 21:5400–13.Google Scholar
  11. 11.
    Lu LJ, Randerath E, Randerath K. DNA hypomethylation in Morris hepatomas. Cancer Lett 1983; 19:231–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Bedford MT, van H PD. Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res 1987; 47:5274–6.PubMedGoogle Scholar
  13. 13.
    Bernardino J, Roux C, Almeida A et al. DNA hypomethylation in breast cancer: An independent parameter of tumor progression? Cancer Genet Cytogenet 1997; 97:83–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Soares J, Pinto AE, Cunha CV et al. Global DNA hypomethylation in breast carcinoma: Correlation with prognostic factors and tumor progression. Cancer 1999; 85:112–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Feinberg AP, Gehrke CW, Kuo KC et al. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 1988; 48:1159–61.PubMedGoogle Scholar
  16. 16.
    Kim YI, Giuliano A, Hatch KD et al. Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma. Cancer 1994; 74:893–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Qu G, Dubeau L, Narayan A et al. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. Mutat Res 1999; 423:91–101.PubMedGoogle Scholar
  18. 18.
    Liteplo RG, Kerbel RS. Reduced levels of DNA 5-methylcytosine in metastatic variants of the human melanoma cell line MeWo. Cancer Res 1987; 47:2264–7.PubMedGoogle Scholar
  19. 19.
    Ehrlich M, Jiang G, Fiala E et al. Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogene 2002; 21:6694–702.PubMedCrossRefGoogle Scholar
  20. 20.
    Shen L, Fang J, Qiu D et al. Correlation between DNA methylation and pathological changes in human hepatocellular carcinoma. Hepatogastroenterology 1998; 45:1753–9.PubMedGoogle Scholar
  21. 21.
    Cravo M, Pinto R, Fidalgo P et al. Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. Gut 1996; 39:434–8.PubMedGoogle Scholar
  22. 22.
    Jurgens B, Schmitz-Drager BJ, Schulz WA. Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res 1996; 56:5698–703.PubMedGoogle Scholar
  23. 23.
    Alves G, Tatro A, Fanning T. Differential methylation of human LINE-1 retrotransposons in malignant cells. Gene 1996; 176:39–44.PubMedCrossRefGoogle Scholar
  24. 24.
    Narayan A, Ji W, Zhang XY et al. Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int J Cancer 1998; 77:833–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Qu GZ, Grundy PE, Narayan A et al. Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet Cytogenet 1999; 109:34–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Kaneko Y, Shibuya M, Nakayama T et al. Hypomethylation of c-myc and epidermal growth factor receptor genes in human hepatocellular carcinoma and fetal liver. Jpn J Cancer Res 1985; 76:1136–40.PubMedGoogle Scholar
  27. 27.
    Del SL., Maestri I, Piva R et al. Differential hypomethylation of the c-myc protooncogene in bladder cancers at different stages and grades. J Urol 1989; 142:146–9.Google Scholar
  28. 28.
    Lipsanen V, Leinonen P, Alhonen L et al. Hypomethylation of ornithine decarboxylase gene and erb-A1 oncogene in human chronic lymphatic leukemia. Blood 1988; 72:2042–4.PubMedGoogle Scholar
  29. 29.
    Nakamura N, Takenaga K. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin Exp Metastasis 1998; 16:471–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Rosty C, Ueki T, Argani P et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol 2002; 160:45–50.PubMedGoogle Scholar
  31. 31.
    Guo Y, Pakneshan P, Gladu J et al. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion. J Biol Chem 2002 Nov 1; 277:41571–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Nakayama M, Wada M, Harada T et al. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. Blood 1998; 92:4296–307.PubMedGoogle Scholar
  33. 33.
    Razin A, Riggs AD. DNA methylation and gene function. Science 1980; 210:604–10.PubMedCrossRefGoogle Scholar
  34. 34.
    Issa JP, Vertino PM, Wu J et al. Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 1993; 85:1235–40.PubMedCrossRefGoogle Scholar
  35. 35.
    Potter J. Methyl supply, methyl metabolizing enzymes and colorectal neoplasia. J Nutr 2002; 132:2410S–2S.PubMedGoogle Scholar
  36. 36.
    Piyathilake CJ, Johanning GL, Macaluso M et al. Localized folate and vitamin B-12 deficiency in squamous cell lung cancer is associated with global DNA hypomethylation. Nutr Cancer 2000; 37:99–107.PubMedCrossRefGoogle Scholar
  37. 37.
    Wilson MJ, Shivapurkar N, Poirier LA. Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyl-deficient diet. Biochem J 1984; 218:987–90.PubMedGoogle Scholar
  38. 38.
    Simile MM, Pascale R, De Miglio MR et al. Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. Cancer Lett 1994; 79:9–16.PubMedCrossRefGoogle Scholar
  39. 39.
    Szyf M, Theberge J, Bozovic V. Ras induces a general DNA demethylation activity in mouse embryonal P19 cells. J Biol Chem 1995; 270:12690–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Szyf M. DNA methylation properties: Consequences for pharmacology. Trends Pharmacol Sci 1994; 15:233–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Hsieh CL. Evidence that protein binding specifies sites of DNA demethylation. Mol Cell Biol 1999; 19:46–56.PubMedGoogle Scholar
  42. 42.
    Lin IG, Tomzynski TJ, Ou Q et al. Modulation of DNA binding protein affinity directly affects target site demethylation. Mol Cell Biol 2000; 20:2343–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Han L, Lin IG, Hsieh CL. Protein binding protects sites on stable episomes and in the chromo-some from de novo methylation. Mol Cell Biol 2001; 21:3416–24.PubMedCrossRefGoogle Scholar
  44. 44.
    Kafri T, Gao X, Razin A. Mechanistic aspects of genome-wide demethylation in the preimplantation mouse embryo. Proc Natl Acad Sci USA 1993; 90:10558–62.PubMedCrossRefGoogle Scholar
  45. 45.
    Razin A, Shemer R. DNA methylation in early development. Hum Mol Genet 1995; 4:1751–5.PubMedGoogle Scholar
  46. 46.
    Kafri T, Ariel M, Brandeis M et al. Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. Genes Dev 1992; 6:705–14.PubMedGoogle Scholar
  47. 47.
    Razin A, Webb C, Szyf M et al. Variations in DNA methylation during mouse cell differentiation in vivo and in vitro. Proc Natl Acad Sci USA 1984; 81:2275–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Wilks A, Seldran M, Jost JP. An estrogen-dependent demethylation at the 5′ end of the chicken vitellogenin gene is independent of DNA synthesis. Nucleic Acids Res 1984; 12:1163–77.PubMedCrossRefGoogle Scholar
  49. 49.
    Wilks AF, Cozens PJ, Mattaj IW et al. Estrogen induces a demethylation at the 5′ end region of the chicken vitellogenin gene. Proc Natl Acad Sci USA 1982; 79:4252–5.PubMedCrossRefGoogle Scholar
  50. 50.
    Paroush Z, Keshet I, Yisraeli J et al. Dynamics of demethylation and activation of the alpha-actin gene in myoblasts. Cell 1990; 63:1229–37.PubMedCrossRefGoogle Scholar
  51. 51.
    Yisraeli J, Adelstein RS, Melloul D et al. Muscle-specific activation of a methylated chimeric actin gene. Cell 1986; 46:409–16.PubMedCrossRefGoogle Scholar
  52. 52.
    Szyf M, Eliasson L, Mann V et al. Cellular and viral DNA hypomethylation associated with induction of Epstein-Barr virus lytic cycle. Proc Natl Acad Sci USA 1985; 82:8090–4.PubMedCrossRefGoogle Scholar
  53. 53.
    Oswald J, Engemann S, Lane N et al. Active demethylation of the paternal genome in the mouse zygote. Curr Biol 2000; 10:475–48.PubMedCrossRefGoogle Scholar
  54. 54.
    Razin A, Feldmesser E, Kafri T et al. Cell specific DNA methylation patterns; formation and a nucleosome locking model for their function. Prog Clin Biol Res 1985; 198:239–53.PubMedGoogle Scholar
  55. 55.
    Razin A, Szyf M, Kafri T et al. Replacement of 5-methylcytosine by cytosine: A possible mechanism for transient DNA demethylation during differentiation. Proc Natl Acad Sci USA 1986; 83:2827–31.PubMedCrossRefGoogle Scholar
  56. 56.
    Jost JP, Jost YC. Mechanism of active DNA demethylation during embryonic development and cellular differentiation in vertebrates. Gene 1995; 157:265–6.PubMedCrossRefGoogle Scholar
  57. 57.
    Jost JP, Siegmann M, Sun L et al. Mechanisms of DNA demethylation in chicken embryos. Purification and properties of a 5-methylcytosine-DNA glycosylase. J Biol Chem 1995; 270:9734–9.PubMedCrossRefGoogle Scholar
  58. 58.
    Weiss A, Keshet I, Razin A et al. DNA demethylation in vitro: Involvement of RNA [published erratum appears in Cell 1998 Nov 13;95(4):following 573]. Cell 1996; 86:709–18.PubMedCrossRefGoogle Scholar
  59. 59.
    Zhu B, Zheng Y, Hess D et al. 5-methylcytosine-DNA glycosylase activity is present in a cloned G/T mismatch DNA glycosylase associated with the chicken embryo DNA demethylation complex. Proc Natl Acad Sci USA 2000 May 9; 97:5135–9.PubMedCrossRefGoogle Scholar
  60. 60.
    Zhu B, Zheng Y, Angliker H et al. 5-Methylcytosine DNA glycosylase activity is also present in the human MBD4 (G/T mismatch glycosylase) and in a related avian sequence. Nucleic Acids Res 2000 Nov 1; 28:4157–65.PubMedCrossRefGoogle Scholar
  61. 61.
    Jost J, Oakeley E, Zhu B et al. 5-Methylcytosine DNA glycosylase participates in the genome-wide loss of DNA methylation occurring during mouse myoblast differentiation. Nucleic Acids Res 2001 Nov 1; 29:4452–61.PubMedCrossRefGoogle Scholar
  62. 62.
    Oswald J, Engemann S, Lane N et al. Active demethylation of the paternal genome in the mouse zygote. Curr Biol 2000; 10:475–8.PubMedCrossRefGoogle Scholar
  63. 63.
    Ramchandani S, Bhattacharya SK, Cervoni N et al. DNA methylation is a reversible biological signal [see comments]. Proc Natl Acad Sci USA 1999; 96:6107–12.PubMedCrossRefGoogle Scholar
  64. 64.
    Cervoni N, Bhattacharya S, Szyf M. DNA demethylase is a processive enzyme. J Biol Chem 1999; 274:8363–6.PubMedCrossRefGoogle Scholar
  65. 65.
    Bhattacharya SK, Ramchandani S, Cervoni N et al. A mammalian protein with specific demethylase activity for mCpG DNA [see comments]. Nature 1999; 397:579–83.PubMedCrossRefGoogle Scholar
  66. 66.
    Hendrich B, Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 1998; 18:6538–47.PubMedGoogle Scholar
  67. 67.
    Zhang Y, Ng HH, Erdjument-Bromage H et al. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 1999; 13:1924–35.PubMedCrossRefGoogle Scholar
  68. 68.
    Ng HH, Zhang Y, Hendrich B et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex [see comments]. Nat Genet 1999; 23:58–61.PubMedGoogle Scholar
  69. 69.
    Boeke J, Ammerpohl O, Kegel S et al. The minimal repression domain of MBD2b overlaps with the Methyl-CpG binding domain and binds directly to Sin3A. J Biol Chem 2000.Google Scholar
  70. 70.
    Cervoni N, Szyf M. Demethylase activity is directed by histone acetylation. J Biol Chem 2001; 276:40778–4087.PubMedCrossRefGoogle Scholar
  71. 71.
    Detich N, Theberge J, Szyf M. Promoter-specific Activation and Demethylation by MBD2/Demethylase. J Biol Chem 2002 Sep 27; 277:35791–4.PubMedCrossRefGoogle Scholar
  72. 72.
    Koizume S, Tachibana K, Sekiya T et al. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. Nucleic Acids Res 2002; 30:4770–80.PubMedCrossRefGoogle Scholar
  73. 73.
    Ghoshal K, Datta J, Majumder S et al. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Mol Cell Biol 2002; 22:8302–19.PubMedCrossRefGoogle Scholar
  74. 74.
    Fournier C, Goto Y, Ballestar E et al. Allele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes. Embo J 2002; 21:6560–70.PubMedCrossRefGoogle Scholar
  75. 75.
    Marhold J, Zbylut M, Lankenau D et al. Stage-specific chromosomal association of Drosophila dMBD2/3 during genome activation. Chromosoma 2002 Mar; 111:13–21.PubMedCrossRefGoogle Scholar
  76. 76.
    Hendrich B, Guy J, Ramsahoye B et al. Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev 2001; 15:710–23.PubMedCrossRefGoogle Scholar
  77. 77.
    Slack A, Bovenzi V, Bigey P et al. Antisense MBD2 gene therapy inhibits tumorigenesis. J Gene Med 2002; 4:381–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Szyf M, Detich N. Regulation of the DNA methylation machinery and its role in cellular transformation. Prog Nucleic Acid Res Mol Biol 2001; 69:47–79.PubMedCrossRefGoogle Scholar
  79. 79.
    Szyf M. The role of DNA methyltransferase 1 in growth control. Front Biosci 2001; 6:D599–609.PubMedGoogle Scholar
  80. 80.
    Fuks F, Burgers WA, Brehm A et al. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet 2000; 24:88–91.PubMedCrossRefGoogle Scholar
  81. 81.
    Robertson KD, Ait-Si-Ali S, Yokochi T et al. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 2000; 25:338–42.PubMedCrossRefGoogle Scholar
  82. 82.
    Di CL, Raker V, Corsaro M et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 2002 Feb 8; 295:1079–82.CrossRefGoogle Scholar
  83. 83.
    Ghoshal K, Datta J, Majumder S et al. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Mol Cell Biol 2002 Dec; 22:8302–19.PubMedCrossRefGoogle Scholar
  84. 84.
    Cameron EE, Bachman KE, Myohanen S et al. Synergy of demethylation and histone deacetylase inhibition in the re expression of genes silenced in cancer. Nat Genet 1999; 21:103–7.PubMedCrossRefGoogle Scholar
  85. 85.
    Kouzarides T. Histone methylation in transcriptional control. Curr Opin Genet Dev 2002; 12:198–209.PubMedCrossRefGoogle Scholar
  86. 86.
    Nguyen CT, Weisenberger DJ, Velicescu M et al. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res 2002; 62:6456–61.PubMedGoogle Scholar
  87. 87.
    Kondo Y, Shen L, Issa JP. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol 2003; 23:206–15.PubMedCrossRefGoogle Scholar
  88. 88.
    Fuks F, Hurd PJ, Wolf D et al. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 2002.Google Scholar
  89. 89.
    Seo SB, McNamara P, Heo S et al. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 2001; 104:119–30.PubMedCrossRefGoogle Scholar
  90. 90.
    Razin A, Cedar H. Distribution of 5-methylcytosine in chromatin. Proc Natl Acad Sci USA 1977; 74:2725–8.PubMedCrossRefGoogle Scholar
  91. 91.
    Kirillov A, Kistler B, Mostoslavsky R et al. A role for nuclear NF-kappaB in B-cell-specific demethylation of the Igkappa locus. Nat Genet 1996; 13:435–41.PubMedCrossRefGoogle Scholar
  92. 92.
    Cui H, Fedoroff N. Inducible DNA demethylation mediated by the maize suppressor-mutator transposon-encoded TnpA protein. Plant Cell 2002; 14:2883–99.PubMedCrossRefGoogle Scholar
  93. 93.
    Cervoni N, Detich N, Seo S et al. The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing. J Biol Chem 2002 Jul 12; 277:25026–31.PubMedCrossRefGoogle Scholar
  94. 94.
    Bhave MR, Wilson MJ, Poirier LA. c-H-ras and c-K-ras gene hypomethylation in the livers and hepatomas of rats fed methyl-deficient, amino acid-defined diets. Carcinogenesis 1988; 9:343–8.PubMedCrossRefGoogle Scholar
  95. 95.
    Wainfan E, Dizik M, Stender M et al. Rapid appearance of hypomethylated DNA in livers of rats fed cancer-promoting, methyl-deficient diets. Cancer Res 1989; 49:4094–7.PubMedGoogle Scholar
  96. 96.
    Dizik M, Christman JK, Wainfan E. Alterations in expression and methylation of specific genes in livers of rats fed a cancer promoting methyl-deficient diet. Carcinogenesis 1991; 12:1307–12.PubMedCrossRefGoogle Scholar
  97. 97.
    Poirier LA. The effects of diet, genetics and chemicals on toxicity and aberrant DNA methylation: An introduction. J Nutr 2002; 132:2336S–9S.PubMedGoogle Scholar
  98. 98.
    Rao PM, Antony A, Rajalakshmi S et al. Studies on hypomethylation of liver DNA during early stages of chemical carcinogenesis in rat liver. Carcinogenesis 1989; 10:933–7.PubMedCrossRefGoogle Scholar
  99. 99.
    Pascale R, Simile M, De MM et al. Chemoprevention of hepatocarcinogenesis. S-adenosyl-L-methionine. Alcohol 2002; 27:193.PubMedCrossRefGoogle Scholar
  100. 100.
    Pascale R, Simile MM, Ruggiu ME et al. Reversal by 5-azacytidine of the S-adenosyl-L-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesis. Cancer Lett 1991; 56:259–65.PubMedCrossRefGoogle Scholar
  101. 101.
    Giovannucci E, Rimm EB, Ascherio A et al. Alcohol, low-methionine—low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 1995; 87:265–73.PubMedCrossRefGoogle Scholar
  102. 102.
    Giovannucci E, Stampfer MJ, Colditz GA et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993; 85:875–84.PubMedCrossRefGoogle Scholar
  103. 103.
    Habets GG, van der Kammen RA, Scholtes EH et al. Induction of invasive and metastatic potential in mouse T-lymphoma cells (BW5147) by treatment with 5-azacytidine. Clin Exp Metastasis 1990; 8:567–77.PubMedCrossRefGoogle Scholar
  104. 104.
    Alvarez E, Elliott BE, Houghton AN et al. Heritable high frequency modulation of antigen expression in neoplastic cells exposed to 5-aza-2′-deoxycytidine or hydroxyurea: Analysis and implications. Cancer Res 1988; 48:2440–5.PubMedGoogle Scholar
  105. 105.
    Takenaga K. Modification of the metastatic potential of tumor cells by drugs. Cancer Metastasis Rev 1986; 5:67–75.PubMedCrossRefGoogle Scholar
  106. 106.
    Nambu S, Inoue K, Saski H. Site-specific hypomethylation of the c-myc oncogene in human hepatocellular carcinoma. Jpn J Cancer Res 1987; 78:695–704.PubMedGoogle Scholar
  107. 107.
    Munzel P, Bock KW. Hypomethylation of c-myc proto-oncogene of N-nitrosomorpholine—in-duced rat liver nodules and of H4IIE cells. Arch Toxicol Suppl 1989; 13:211–3.PubMedGoogle Scholar
  108. 108.
    Vorce RL, Goodman JI. Altered methylation of ras oncogenes in benzidine-induced B6C3F1 mouse liver tumors. Toxicol Appl Pharmacol 1989; 100:398–410.PubMedCrossRefGoogle Scholar
  109. 109.
    Vorce RL, Goodman JI. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors. J Toxicol Environ Health 1991; 34:367–84.PubMedCrossRefGoogle Scholar
  110. 110.
    Hansen RS, Wijmenga C, Luo P et al. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci USA 1999; 96:14412–7.PubMedCrossRefGoogle Scholar
  111. 111.
    Okano M, Bell DW, Haber DA et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 99:247–57.PubMedCrossRefGoogle Scholar
  112. 112.
    Schuffenhauer S, Bartsch O, Stumm M et al. DNA, FISH and complementation studies in ICF syndrome: DNA hypomethylation of repetitive and single copy loci and evidence for a trans acting factor. Hum Genet 1995; 96:562–71.PubMedCrossRefGoogle Scholar
  113. 113.
    Ji W, Hernandez R, Zhang XY et al. DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat Res 1997; 379:33–41.PubMedGoogle Scholar
  114. 114.
    Chen RZ, Pettersson U, Beard C et al. DNA hypomethylation leads to elevated mutation rates. Nature 1998; 395:89–93.PubMedCrossRefGoogle Scholar
  115. 115.
    Ehrlich M. DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements. J Nutr 2002 Aug; 132:2424S–9S.PubMedGoogle Scholar
  116. 116.
    Grigorian MS, Tulchinsky EM, Zain S et al. The mts1 gene and control of tumor metastasis. Gene 1993; 135:229–38.PubMedCrossRefGoogle Scholar
  117. 117.
    Ford HL, Salim MM, Chakravarty R et al. Expression of Mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line. Oncogene 1995; 11:2067–75.PubMedGoogle Scholar
  118. 118.
    Grigorian M, Ambartsumian N, Lykkesfeldt AE et al. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int J Cancer 1996; 67:831–41.PubMedCrossRefGoogle Scholar
  119. 119.
    MacDougall JR, Bani MR, Lin Y et al. ‘Proteolytic switching’: Opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression. Br J Cancer 1999; 80:504–12.PubMedCrossRefGoogle Scholar
  120. 120.
    Beaulieu N, Morin S, Chute I et al. An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J Biol Chem 2002; 277:28176–81.PubMedCrossRefGoogle Scholar
  121. 121.
    Szyf M. The DNA Methylation Machinery as a Therapeutic target. Current Drug Targets 2000; 1:101–18.PubMedCrossRefGoogle Scholar
  122. 122.
    Jones PA. Altering gene expression with 5-azacytidine. Cell 1985; 40:485–6.PubMedCrossRefGoogle Scholar
  123. 123.
    Wu JC, Santi DV. On the mechanism and inhibition of DNA cytosine methyltransferases. Prog Clin Biol Res 1985; 198:119–29.PubMedGoogle Scholar
  124. 124.
    Tulchinsky E, Grigorian M, Tkatch T et al. Transcriptional regulation of the mts1 gene in human lymphoma cells: The role of DNA-methylation. Biochim Biophys Acta 1995; 1261:243–8.PubMedGoogle Scholar
  125. 125.
    Milutinovic S, Zhuang Q, Niveleau A et al. Epigenomic stress response. Knockdown of DNA methyltransferase 1 triggers an intra-S-phase arrest of DNA replication and induction of stress response genes. J Biol Chem 2003; 278(17):14985–95.PubMedCrossRefGoogle Scholar
  126. 126.
    Campbell PM, Bovenzi V, Szyf M. Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo. Carcinogenesis 2004; (4):499–507.Google Scholar

Copyright information

© Eurekah.com and Kluwer Academic/Plenum Publishers 2005

Authors and Affiliations

  • Moshe Szyf
    • 1
  • Paul M. Campbell
    • 1
  • Nancy Detich
    • 1
  • Jing Ni Ou
    • 1
  • Stefan Hamm
    • 1
  • Veronica Bovenzi
    • 1
  1. 1.Department of Pharmacology and TherapeuticsMcGill UniversityMontrealCanada

Personalised recommendations